CIMChimera Investment Corporation

$8.98-30% 1Y

Is the price fair?

Mixed

In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 neutral, 2 without data
Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 7.0 vs a 7.0 median over 18 quarters (−0% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What CIM's price assumes

Chimera Investment Corporation has no trailing P/E on file, so the price is measured against sales instead: 4.08× revenue.

4.08

Price / sales · no trailing P/E on file: measured against sales instead

Price / book
0.47

Price / book · as of 2026-Q2

EV / sales
3.39

EV / sales

Details›
Price / bookas of 2026-Q2
0.47
EV / salesas of 2026-Q2
3.39
Market capitalisation
$1.13B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

On our screens:Stocks with no debt